Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126674291 | 12667429 | 1 | I | 20160812 | 20160819 | 20160819 | PER | US-PFIZER INC-2016388387 | PFIZER | 11.00 | YR | M | Y | 63.00000 | KG | 20160819 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126674291 | 12667429 | 1 | PS | CRIZOTINIB | CRIZOTINIB | 1 | UNK | U | 202570 | ||||||||||
| 126674291 | 12667429 | 2 | SS | MITOXANTRONE HCL | MITOXANTRONE HYDROCHLORIDE | 1 | UNK | U | 76871 | ||||||||||
| 126674291 | 12667429 | 3 | SS | VINCRISTINE SULFATE. | VINCRISTINE SULFATE | 1 | UNK | U | 71484 | ||||||||||
| 126674291 | 12667429 | 4 | SS | ERWINIA | ASPARAGINASE ERWINIA CHRYSANTHEMI | 1 | UNK | U | 0 | ||||||||||
| 126674291 | 12667429 | 5 | SS | DEX | DEXAMETHASONE | 1 | UNK | U | 0 | ||||||||||
| 126674291 | 12667429 | 6 | C | DILAUDID | HYDROMORPHONE HYDROCHLORIDE | 1 | UNK | 0 | ORAL SOLUTION | ||||||||||
| 126674291 | 12667429 | 7 | C | DILAUDID | HYDROMORPHONE HYDROCHLORIDE | 1 | Oral | UNK, AS NEEDED (1 MG/ML) | 0 | ORAL SOLUTION | |||||||||
| 126674291 | 12667429 | 8 | C | DILAUDID | HYDROMORPHONE HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | UNK, AS NEEDED (0.5 MG 0.25 ML) | 0 | ORAL SOLUTION | |||||||||
| 126674291 | 12667429 | 9 | C | DILAUDID | HYDROMORPHONE HYDROCHLORIDE | 1 | Oral | UNK, AS NEEDED (1.5 MG 1.5 ML) | 0 | ORAL SOLUTION | |||||||||
| 126674291 | 12667429 | 10 | C | NORMAL SALINE | SODIUM CHLORIDE | 1 | Intravenous (not otherwise specified) | UNK | 0 | ||||||||||
| 126674291 | 12667429 | 11 | C | TYLENOL | ACETAMINOPHEN | 1 | UNK, AS NEEDED (650 MG 20.3 ML) | 0 | ORAL SUSPENSION | ||||||||||
| 126674291 | 12667429 | 12 | C | TYLENOL | ACETAMINOPHEN | 1 | Oral | UNK, AS NEEDED (500 MG 15.2 ML) | 0 | ORAL SUSPENSION | |||||||||
| 126674291 | 12667429 | 13 | C | BIOTENE MOUTHWASH | CETYLPYRIDINIUM CHLORIDE | 1 | 15 ML, 3X/DAY | 0 | 15 | ML | MOUTH WASH | TID | |||||||
| 126674291 | 12667429 | 14 | C | CLONAZEPAM. | CLONAZEPAM | 1 | UNK, 2X/DAY (0.25 MG 2.5 ML) | 0 | ORAL LIQUID | BID | |||||||||
| 126674291 | 12667429 | 15 | C | CLONAZEPAM. | CLONAZEPAM | 1 | Oral | UNK, 2X/DAY (.1 MG/ML) (2.5 CC) | 0 | ORAL LIQUID | BID | ||||||||
| 126674291 | 12667429 | 16 | C | DIPHENHYDRAMINE. | DIPHENHYDRAMINE | 1 | Intravenous (not otherwise specified) | UNK, AS NEEDED (25 MG 0.5 ML) | 0 | INJECTION | |||||||||
| 126674291 | 12667429 | 17 | C | BENADRYL | DIPHENHYDRAMINE HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | UNK, AS NEEDED (25 MG 0.5 ML) | 0 | INJECTION | |||||||||
| 126674291 | 12667429 | 18 | C | NEUPOGEN | FILGRASTIM | 1 | Intravenous (not otherwise specified) | UNK, DAILY (340 MCG 17 ML) | 0 | INJECTION | |||||||||
| 126674291 | 12667429 | 19 | C | FUROSEMIDE. | FUROSEMIDE | 1 | Intravenous (not otherwise specified) | UNK (30 MG 3 ML ) (Q6H) | 0 | INJECTION | |||||||||
| 126674291 | 12667429 | 20 | C | DOTAREM | GADOTERATE MEGLUMINE | 1 | Intravenous (not otherwise specified) | UNK (13.7 ML) | 0 | ||||||||||
| 126674291 | 12667429 | 21 | C | GRANISETRON | GRANISETRON | 1 | Intravenous (not otherwise specified) | UNK (1 MG 1 ML) (Q12H) | 0 | INJECTION | |||||||||
| 126674291 | 12667429 | 22 | C | HEPARIN FLUSH | HEPARIN SODIUM | 1 | Intravenous (not otherwise specified) | UNK, AS NEEDED (300 UNITS 3 ML) | 0 | INJECTION | |||||||||
| 126674291 | 12667429 | 23 | C | HYDROCORTISONE. | HYDROCORTISONE | 1 | Intravenous (not otherwise specified) | UNK, AS NEEDED (100 MG 2 ML) | 0 | INJECTION | |||||||||
| 126674291 | 12667429 | 24 | C | LEVOCARNITINE. | LEVOCARNITINE | 1 | Oral | UNK, 3X/DAY (100 MG/ML) | 0 | ORAL SOLUTION | TID | ||||||||
| 126674291 | 12667429 | 25 | C | LIDOCAINE. | LIDOCAINE | 1 | Subcutaneous | 0.2 UNK, AS NEEDED | 0 | .2 | ML | ||||||||
| 126674291 | 12667429 | 26 | C | LIDOCAINE. | LIDOCAINE | 1 | UNK | 0 | |||||||||||
| 126674291 | 12667429 | 27 | C | LIDOCAINE. | LIDOCAINE | 1 | Intravenous (not otherwise specified) | 0.2 UNK, AS NEEDED | 0 | ||||||||||
| 126674291 | 12667429 | 28 | C | LINEZOLID. | LINEZOLID | 1 | Intravenous (not otherwise specified) | UNK (600 MG/ 300 ML IV Q12 H) | 0 | ||||||||||
| 126674291 | 12667429 | 29 | C | ATIVAN | LORAZEPAM | 1 | Intravenous (not otherwise specified) | UNK, 3X/DAY (0.25 MG 0.13 ML) | 0 | ORAL SUSPENSION | TID | ||||||||
| 126674291 | 12667429 | 30 | C | ATIVAN | LORAZEPAM | 1 | Intravenous (not otherwise specified) | UNK, AS NEEDED (0.5 MG 0.25 ML) | 0 | ORAL SUSPENSION | |||||||||
| 126674291 | 12667429 | 31 | C | ATIVAN | LORAZEPAM | 1 | 0 | ORAL SUSPENSION | |||||||||||
| 126674291 | 12667429 | 32 | C | MEROPENEM. | MEROPENEM | 1 | Intravenous (not otherwise specified) | UNK (2000 MG/100 ML IV Q8H) | 0 | ||||||||||
| 126674291 | 12667429 | 33 | C | FLAGYL | METRONIDAZOLEMETRONIDAZOLE HYDROCHLORIDE | 1 | Intravenous (not otherwise specified) | UNK (500 MG/100 ML IV Q8H) | 0 | ||||||||||
| 126674291 | 12667429 | 34 | C | MICAFUNGIN | MICAFUNGIN | 1 | Intravenous (not otherwise specified) | UNK, DAILY (150 MG/150 ML) | 0 | ||||||||||
| 126674291 | 12667429 | 35 | C | NYSTATIN. | NYSTATIN | 1 | UNK, 4X/DAY (10 ML SWISH AND SWALLOW QID) | 0 | QID | ||||||||||
| 126674291 | 12667429 | 36 | C | MOUTH WASH | 2 | Oral | UNK, AS NEEDED (5 ML ORAL Q2H PRN) | 0 | MOUTH WASH | ||||||||||
| 126674291 | 12667429 | 37 | C | MOUTH WASH | 2 | Oral | UNK, AS NEEDED (5 ML ORAL Q2H PRN) | 0 | MOUTH WASH | ||||||||||
| 126674291 | 12667429 | 38 | C | ZOFRAN | ONDANSETRON HYDROCHLORIDE | 1 | Oral | 8 MG, UNK (8 MG ORAL Q8H) | 0 | 8 | MG | MODIFIED-RELEASE TABLET | |||||||
| 126674291 | 12667429 | 39 | C | ZOFRAN | ONDANSETRON HYDROCHLORIDE | 1 | Oral | 4 MG, AS NEEDED (4 MG 1 TAB ORAL Q8H) | 0 | 4 | MG | MODIFIED-RELEASE TABLET | |||||||
| 126674291 | 12667429 | 40 | C | PENTAFLUOROPROPANE W/TETRAFLUOROETHANE | 2 | Topical | 1 DF, AS NEEDED | 0 | 1 | DF | |||||||||
| 126674291 | 12667429 | 41 | C | PENTAMIDINE | PENTAMIDINE | 1 | UNK (300 MG/5 ML) | 0 | |||||||||||
| 126674291 | 12667429 | 42 | C | PENTAMIDINE | PENTAMIDINE | 1 | UNK | 0 | |||||||||||
| 126674291 | 12667429 | 43 | C | MIRALAX | POLYETHYLENE GLYCOL 3350 | 1 | Oral | UNK, DAILY (17 GM 1 PACKET) | 0 | ||||||||||
| 126674291 | 12667429 | 44 | C | RANITIDINE. | RANITIDINE | 1 | Intravenous (not otherwise specified) | UNK, AS NEEDED (50 MG 25 ML INJ IV ONE TIME PRN) | 0 | ||||||||||
| 126674291 | 12667429 | 45 | C | ZANTAC | RANITIDINE HYDROCHLORIDE | 1 | Oral | UNK, 2X/DAY (15 MG/ML) (150MG=10ML) | 0 | SYRUP | BID | ||||||||
| 126674291 | 12667429 | 46 | C | SARGRAMOSTIM | SARGRAMOSTIM | 1 | Intravenous (not otherwise specified) | UNK, CYCLIC (400 MCG 20 ML INJ IV DAILY) | 0 | ||||||||||
| 126674291 | 12667429 | 47 | C | SODIUM CHLORIDE. | SODIUM CHLORIDE | 1 | Intravenous (not otherwise specified) | 1 ML, AS NEEDED | 0 | 1 | ML | ||||||||
| 126674291 | 12667429 | 48 | C | ALDACTONE | SPIRONOLACTONE | 1 | Oral | 25 MG, 2X/DAY | 0 | 25 | MG | TABLET | BID | ||||||
| 126674291 | 12667429 | 49 | C | ACTIGALL | URSODIOL | 1 | Oral | UNK, 2X/DAY (300 MG 5 ML) | 0 | BID | |||||||||
| 126674291 | 12667429 | 50 | C | ACTIGALL | URSODIOL | 1 | 0 | ||||||||||||
| 126674291 | 12667429 | 51 | C | LEVOCARNITINE. | LEVOCARNITINE | 1 | Intravenous (not otherwise specified) | UNK, 3X/DAY (1000MG 5ML) | 0 | INJECTION | TID | ||||||||
| 126674291 | 12667429 | 52 | C | LIDOCAINE. | LIDOCAINE | 1 | Topical | UNK, AS NEEDED | 0 | ||||||||||
| 126674291 | 12667429 | 53 | C | ARTIFICIAL TEARS /00222401/ | 2 | 2 DROP (S) EYES, BOTH TID PRN | 0 | 2 | GTT | TID |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126674291 | 12667429 | 1 | B-cell type acute leukaemia |
| 126674291 | 12667429 | 2 | B-cell type acute leukaemia |
| 126674291 | 12667429 | 3 | B-cell type acute leukaemia |
| 126674291 | 12667429 | 4 | B-cell type acute leukaemia |
| 126674291 | 12667429 | 5 | B-cell type acute leukaemia |
| 126674291 | 12667429 | 6 | Pain |
| 126674291 | 12667429 | 11 | Pain |
| 126674291 | 12667429 | 12 | Pyrexia |
| 126674291 | 12667429 | 16 | Pruritus |
| 126674291 | 12667429 | 25 | Phlebotomy |
| 126674291 | 12667429 | 29 | Anxiety |
| 126674291 | 12667429 | 30 | Nausea |
| 126674291 | 12667429 | 31 | Vomiting |
| 126674291 | 12667429 | 32 | Meningitis |
| 126674291 | 12667429 | 33 | Infection |
| 126674291 | 12667429 | 34 | Infection |
| 126674291 | 12667429 | 36 | Oral pain |
| 126674291 | 12667429 | 38 | Nausea |
| 126674291 | 12667429 | 39 | Vomiting |
| 126674291 | 12667429 | 40 | Phlebectomy |
| 126674291 | 12667429 | 41 | Evidence based treatment |
| 126674291 | 12667429 | 43 | Constipation |
| 126674291 | 12667429 | 44 | Hypersensitivity |
| 126674291 | 12667429 | 49 | Cholestasis |
| 126674291 | 12667429 | 50 | Parenteral nutrition |
| 126674291 | 12667429 | 53 | Dry eye |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126674291 | 12667429 | B-cell type acute leukaemia | |
| 126674291 | 12667429 | Disease progression | |
| 126674291 | 12667429 | Product use issue | |
| 126674291 | 12667429 | Transaminases increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126674291 | 12667429 | 6 | 20160807 | 0 | ||
| 126674291 | 12667429 | 7 | 20160722 | 0 | ||
| 126674291 | 12667429 | 8 | 20160811 | 0 | ||
| 126674291 | 12667429 | 9 | 20160729 | 0 | ||
| 126674291 | 12667429 | 10 | 20160726 | 0 | ||
| 126674291 | 12667429 | 11 | 20160730 | 0 | ||
| 126674291 | 12667429 | 12 | 20160727 | 0 | ||
| 126674291 | 12667429 | 13 | 20160805 | 0 | ||
| 126674291 | 12667429 | 14 | 20160726 | 0 | ||
| 126674291 | 12667429 | 15 | 20160722 | 0 | ||
| 126674291 | 12667429 | 16 | 20160807 | 0 | ||
| 126674291 | 12667429 | 17 | 20160730 | 0 | ||
| 126674291 | 12667429 | 18 | 20160807 | 0 | ||
| 126674291 | 12667429 | 19 | 20160810 | 0 | ||
| 126674291 | 12667429 | 20 | 20160809 | 0 | ||
| 126674291 | 12667429 | 21 | 20160802 | 0 | ||
| 126674291 | 12667429 | 22 | 20160726 | 0 | ||
| 126674291 | 12667429 | 23 | 20160730 | 0 | ||
| 126674291 | 12667429 | 24 | 20160722 | 0 | ||
| 126674291 | 12667429 | 25 | 20160726 | 0 | ||
| 126674291 | 12667429 | 26 | 20160726 | 0 | ||
| 126674291 | 12667429 | 27 | 20160726 | 0 | ||
| 126674291 | 12667429 | 28 | 20160808 | 0 | ||
| 126674291 | 12667429 | 30 | 20160727 | 0 | ||
| 126674291 | 12667429 | 32 | 20160807 | 0 | ||
| 126674291 | 12667429 | 33 | 20160811 | 0 | ||
| 126674291 | 12667429 | 34 | 20160809 | 0 | ||
| 126674291 | 12667429 | 35 | 20160807 | 0 | ||
| 126674291 | 12667429 | 36 | 20160805 | 0 | ||
| 126674291 | 12667429 | 37 | 20160805 | 0 | ||
| 126674291 | 12667429 | 38 | 20160722 | 0 | ||
| 126674291 | 12667429 | 39 | 20160804 | 0 | ||
| 126674291 | 12667429 | 40 | 20160726 | 0 | ||
| 126674291 | 12667429 | 41 | 20160801 | 0 | ||
| 126674291 | 12667429 | 42 | 20160722 | 0 | ||
| 126674291 | 12667429 | 43 | 20160805 | 0 | ||
| 126674291 | 12667429 | 44 | 20160727 | 0 | ||
| 126674291 | 12667429 | 45 | 20160722 | 0 | ||
| 126674291 | 12667429 | 46 | 20160810 | 0 | ||
| 126674291 | 12667429 | 47 | 20160726 | 0 | ||
| 126674291 | 12667429 | 48 | 20160810 | 0 | ||
| 126674291 | 12667429 | 49 | 20160726 | 0 | ||
| 126674291 | 12667429 | 51 | 20160726 | 0 | ||
| 126674291 | 12667429 | 53 | 20160731 | 0 |